Phospholamban gene dosage effects in the mammalian heart.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 8620604)

Published in Circ Res on May 01, 1996

Authors

W Luo1, B M Wolska, I L Grupp, J M Harrer, K Haghighi, D G Ferguson, J P Slack, G Grupp, T Doetschman, R J Solaro, E G Kranias

Author Affiliations

1: Department of Pharmacology, University of Cincinnati, College of Medicine, Ohio 45267-0575, USA.

Articles citing this

Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res (2012) 2.06

Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol (1997) 1.73

Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circ Res (2009) 1.52

Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol (1998) 1.32

Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One (2009) 1.28

Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev (2009) 1.19

The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate. Pflugers Arch (2008) 0.99

The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. J Mol Cell Cardiol (2011) 0.93

Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A. J Biol Chem (2012) 0.92

Phospholamban overexpression in transgenic rabbits. Transgenic Res (2007) 0.91

A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids. Hum Mutat (2008) 0.91

SERCA2a: a prime target for modulation of cardiac contractility during heart failure. BMB Rep (2013) 0.85

Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport. Am J Physiol Heart Circ Physiol (2008) 0.84

Tropomyosin dephosphorylation results in compensated cardiac hypertrophy. J Biol Chem (2012) 0.81

Two-pore Channels (TPC2s) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) at Lysosomal-Sarcoplasmic Reticular Junctions Contribute to Acute and Chronic β-Adrenoceptor Signaling in the Heart. J Biol Chem (2015) 0.80

Role of AMPK α in skeletal muscle glycometabolism regulation and adaptation in relation to sepsis. Biomed Res Int (2014) 0.78

Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle. PLoS One (2015) 0.77

Articles by these authors

TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 6.31

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res (1994) 5.01

Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet (1995) 4.46

Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet (1998) 3.96

Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium. J Cell Biol (1995) 3.28

Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci U S A (1986) 3.11

Molecular architecture of membranes involved in excitation-contraction coupling of cardiac muscle. J Cell Biol (1995) 2.88

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68

Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature (1976) 2.65

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63

Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1989) 2.59

The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta (1971) 2.45

Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res (2001) 2.45

Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34

The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem (1982) 2.27

Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation (2001) 2.23

Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest (1999) 2.22

Fibroblast growth factor 2 control of vascular tone. Nat Med (1998) 2.21

Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18

Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. Circ Res (1998) 2.16

Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem (1999) 2.15

Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development (1988) 2.12

Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol Cell Biol (1993) 2.12

Balance and hearing deficits in mice with a null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2. J Biol Chem (1998) 2.10

Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol (1996) 2.08

Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res (1999) 2.01

Subunit structure of junctional feet in triads of skeletal muscle: a freeze-drying, rotary-shadowing study. J Cell Biol (1984) 1.99

Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genomics (2001) 1.98

Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol (1999) 1.95

Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci (1999) 1.93

The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem (1980) 1.89

Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet (1998) 1.89

Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell (1999) 1.88

Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation. J Biol Chem (2001) 1.88

Calcium requirements for cardiac myofibrillar activation. Circ Res (1974) 1.87

Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature (1982) 1.83

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A (1995) 1.81

Phospholamban: a prominent regulator of myocardial contractility. Circ Res (1996) 1.78

Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem (1998) 1.77

Vanadate and phosphate ions reduce tension and increase cross-bridge kinetics in chemically skinned heart muscle. Biochim Biophys Acta (1981) 1.74

Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol (1997) 1.73

Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J (1988) 1.73

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation (2001) 1.72

Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol (1998) 1.72

A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists. J Biol Chem (2000) 1.72

Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68

Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem (1995) 1.64

Targeted disruption of the murine Na+/H+ exchanger isoform 2 gene causes reduced viability of gastric parietal cells and loss of net acid secretion. J Clin Invest (1998) 1.64

In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res (1995) 1.61

Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry (1997) 1.61

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem (1998) 1.60

A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem (1990) 1.60

Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest (1996) 1.59

Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol (2000) 1.57

Effects of diacetyl monoxime on cardiac excitation-contraction coupling. J Pharmacol Exp Ther (1985) 1.57

Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem (1991) 1.56

Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res (1999) 1.55

Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res (1998) 1.54

Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem (1999) 1.52

Replication of bacteriophage phiX174 DNA in a temperature-sensitive dnaC mutant of escherichia coli C. J Virol (1974) 1.51

Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH. J Mol Cell Cardiol (2001) 1.51

Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ Res (1998) 1.50

Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest (1999) 1.49

Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res (1996) 1.48

Genetically engineered mice: model systems for left ventricular failure. J Card Fail (1998) 1.48

Estimating the functional capabilities of sarcoplasmic reticulum in cardiac muscle. Calcium binding. Circ Res (1974) 1.46

Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. J Biol Chem (1987) 1.44

Conformation of the regulatory domain of cardiac muscle troponin C in its complex with cardiac troponin I. J Biol Chem (1999) 1.43

Why do accident and emergency doctors request X-rays? Arch Emerg Med (1984) 1.43

Workload management in A&E: counting the uncountable and predicting the unpredictable. J Accid Emerg Med (1997) 1.41

Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol (2001) 1.40

Keratin 12-deficient mice have fragile corneal epithelia. Invest Ophthalmol Vis Sci (1996) 1.40

Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH. Circ Res (1984) 1.39

Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res (1999) 1.39

TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev Biol (2001) 1.39

Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium. Circ Res (1991) 1.38

The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38

Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem (1990) 1.38

Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol Cell Biol (1993) 1.38

Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol (2000) 1.38

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest (2001) 1.37